[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch Avatar @Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about announces, $snti, $pali, $glmd the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXX% finance XXXX% cryptocurrencies XXXX% technology brands XXXX%

Social topic influence announces 4.94%, $snti #12, $pali #47, $glmd 2.47%, $xcur #22, $ensc #4, $atpc #17, $adct 2.47%, catalyst 2.47%, $mist #28

Top accounts mentioned or mentioned by @maximusholla @monacobiotech @boudin420 @martinshkreli @biostocks @yaireinhorn @amaymd @biotech2k1

Top assets mentioned ADC Therapeutics SA (ADCT) Mist (MIST) Adaptive Biotechnologies Corporation Common Stock (ADPT) Dyne Therapeutics, Inc. Common Stock (DYN) Celcuity Inc. Common Stock (CELC) Geron Corp (GERN)

Top Social Posts

Top posts by engagements in the last XX hours

"Top Market Movers: Negative News Full Access: $GTBP 0.67$ -XXXXX% November XX 2025 GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update"
X Link 2025-11-17T15:45Z 1229 followers, XXX engagements

"$GLMD 1.02$ XXXX% 2025-12-04T13:30:00.000Z Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH"
X Link 2025-12-05T15:45Z 1229 followers, XXX engagements

"Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1"
X Link 2025-12-07T23:27Z 1229 followers, XXX engagements

"$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement"
X Link 2025-12-08T15:45Z 1229 followers, XX engagements

"$ADPT 17.34$ -XXXX% 2025-12-08T00:00:00.000Z Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting"
X Link 2025-12-08T15:45Z 1229 followers, XX engagements

"Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I"
X Link 2025-12-09T15:45Z 1230 followers, XXX engagements

"$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML"
X Link 2025-12-09T15:45Z 1229 followers, XXX engagements

"$GLMD 1.17$ -XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-09T15:45Z 1229 followers, XX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $SNTI - 1.9M - 54.3M - XXXXX $XCUR - 954.0K - 20.1M - XXXXX $ENSC - 237.9K - 5.0M - 21.08"
X Link 2025-12-09T15:45Z 1232 followers, XXX engagements

"$LYEL Catalyst Date - 2025-12-10 Drug - Rondecabtagene autoleucel (ronde-cel) Treatment - Aggressive large B-cell lymphoma (LBCL)"
X Link 2025-12-09T15:45Z 1232 followers, XX engagements

"Top Market Movers: Positive News Full Access: $DYN 20.39$ XXXXX% 2025-12-08T11:30:00.000Z Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD"
X Link 2025-12-10T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $MBRX 5.31$ -XXXXX% 2025-12-08T13:21:00.000Z Moleculin Announces New Annamycin Collaboration in Brain Tumors"
X Link 2025-12-10T15:45Z 1233 followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ATPC - 31.5M - 774.1M - XXXXX $RZLT - 5.9M - 128.7M - XXXXX $ACIU - 920.5K - 20.0M - 21.68"
X Link 2025-12-12T15:45Z 1235 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $PMCB 0.82$ -XXXX% November XX 2025 PharmaCyte Biotech Successfully Monetizes Femasys Stake Strengthening Cash Position and Underscoring Strategic Capital Deployment"
X Link 2025-11-26T15:45Z 1233 followers, XXX engagements

"$PALI 2.06$ -XXXX% November XX 2025 Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference"
X Link 2025-11-26T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $SPRC 1.89$ -XXXXX% 2025-12-01T13:32:00.000Z SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio"
X Link 2025-12-01T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-04T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-05T15:45Z 1233 followers, XXX engagements

"$IMMP 1.75$ -XXXX% 2025-12-03T00:00:00.000Z Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-05T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of"
X Link 2025-12-08T15:45Z 1232 followers, XXX engagements

"$SNWV 31.38$ XXXX% 2025-12-08T11:00:00.000Z Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO) iSupply"
X Link 2025-12-09T15:45Z 1233 followers, XXX engagements

"Latest catalysts: $BMEA Catalyst Date - 2025-11-04 Drug - BMF-650 (next-generation oral small molecule glucagon-like peptide-1 receptor agonist) Treatment - obesity"
X Link 2025-11-04T15:45Z 1233 followers, XXX engagements

"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-04T15:45Z 1233 followers, 1175 engagements

"$PALI 1.74$ -XXXX% 2025-12-03T00:00:00.000Z Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec MD AGAF as Vice President Clinical Development"
X Link 2025-12-04T15:45Z 1233 followers, XXX engagements

"$PALI 1.74$ -XXXX% 2025-12-03T00:00:00.000Z Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec MD AGAF as Vice President Clinical Development"
X Link 2025-12-05T15:45Z 1233 followers, XXX engagements

"$OBIO 4.41$ XXXX% 2025-12-08T12:00:00.000Z Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting"
X Link 2025-12-10T15:45Z 1233 followers, XX engagements

"$MIST Catalyst Date - 2025-12-13 Drug - CARDAMYST (etripamil) Treatment - Paroxysmal supraventricular tachycardia (PSVT)"
X Link 2025-12-11T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $MAIA 1.64$ XXXXX% 2025-12-11T14:00:00.000Z MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase X Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for"
X Link 2025-12-12T15:45Z 1233 followers, XX engagements

"Highest Volume Ticker - Price - Volume $ATPC - 0.18$ - 774.1M $PTPI - 0.07$ - 266.5M $PAVS - 0.03$ - 194.8M $WOK - 0.17$ - 176.3M $OCEA - 0.02$ - 171.4M"
X Link 2025-12-12T15:45Z 1233 followers, XXX engagements

"$SANA 4.21$ XXXX% 2025-12-08T14:00:00.000Z Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform"
X Link 2025-12-08T15:45Z 1233 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $CPIX 2.33$ XXXX% 2025-12-08T14:05:00.000Z CALDOLOR (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT"
X Link 2025-12-09T15:45Z 1233 followers, XXX engagements

"Latest catalysts: $RNXT Catalyst Date - 2025-12-09 Drug - RenovoCath (novel drug-delivery device) Treatment - locally advanced pancreatic cancer"
X Link 2025-12-09T15:45Z 1233 followers, XXX engagements

"$SNTI Catalyst Date - 2025-12-09 Drug - SENTI-202 (first-in-class CD33 and/or FLT3 selective off-the-shelf logic gated CAR NK cell therapy) Treatment - Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)"
X Link 2025-12-09T15:45Z 1233 followers, XX engagements

"Highest Volume Ticker - Price - Volume $LPTX - 2.05$ - 786.0M $PTPI - 0.07$ - 266.5M $BEAT - 1.35$ - 175.3M $OCEA - 0.02$ - 171.4M $CERO - 0.10$ - 114.7M"
X Link 2025-12-10T15:45Z 1233 followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $SNTI - 2.6M - 73.6M - XXXXX $XCUR - 1.3M - 30.4M - XXXXX $ENSC - 269.4K - 6.0M - 22.12"
X Link 2025-12-10T15:45Z 1233 followers, XXX engagements

"Latest catalysts: $CELC Catalyst Date - 2025-12-11 Drug - Gedatolisib (multi-target PI3K/AKT/mTOR inhibitor) Treatment - HR+/HER2-/PIK3CA-wild type advanced breast cancer"
X Link 2025-12-11T15:45Z 1233 followers, XXX engagements

"Latest catalysts: $OLMA Catalyst Date - 2025-12-12 Drug - Palazestrant (OP-1250) Treatment - Estrogen receptor-positive (ER+) human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer"
X Link 2025-12-12T15:45Z 1233 followers, XXX engagements

"$GERN 1.39$ XXXX% 2025-12-11T13:00:00.000Z Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation"
X Link 2025-12-12T15:45Z 1233 followers, XX engagements

"$MIST Catalyst Date - 2025-12-13 Drug - CARDAMYST (etripamil) Treatment - Paroxysmal supraventricular tachycardia (PSVT)"
X Link 2025-12-12T15:45Z 1233 followers, 1152 engagements